ArrePath
Dr. Peter Warn is founder of Magic Bullet Consulting, and is an expert in the development of antimicrobial agents and the development of appropriate animal models of infection. Prior to this, he was Senior Vice President of Anti-infective Discovery at Evotec, where he led antimicrobial discovery programmes and had scientific oversight of external client contracts. Dr. Warn was a co-founder and Chief Scientific Officer of Euprotec prior to the company being acquired by Evotec. Previously he was a senior lecturer at the University of Manchester, leading a research group investigating the pathogenesis and treatment of severe infections. He has also lectured within Molecular Parasitology at the University of Oxford and was a clinical scientist in Public Health England. Peter has published over 80 papers and 400 conference abstracts. Peter holds a PhD in medical sciences from the University of Manchester.
This person is not in the org chart
This person is not in any offices
ArrePath
ArrePath was founded upon the mission to discover new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies. We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues. Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.